Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > SBI Mutual Fund > SBI Pharma Fund (G)

SBI Pharma Fund (G)

PLAN: Regular OPTIONS: Growth
121.175 0.71 (0.59%)

NAV as on 19 Apr, 2018

CRISIL MF RANK

Not Ranked

Riskometer

HIGH

HIGH

  • Principal at high risk.
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
Holdings (Mar 31, 18)
Equity Sector Value
(Rs cr)
Assets %
Cipla Pharmaceuticals 77.62 9.37
Sun Pharma Pharmaceuticals 68.76 8.30
Divis Labs Pharmaceuticals 66.19 7.99
Strides Shasun Pharmaceuticals 63.87 7.71
Alkem Lab Pharmaceuticals 51.78 6.25
Torrent Pharma Pharmaceuticals 47.72 5.76
Cadila Health Pharmaceuticals 43.24 5.22
Aurobindo Pharm Pharmaceuticals 38.69 4.67
Gufic Bio Pharmaceuticals 31.07 3.75
Aster DM Health Conglomerates 30.82 3.72
Sector Allocation (Mar 31, 18)
  Sector   % 1-Year
High Low

Pharmaceuticals

81.67 0.00 0.00

Services

6.14 0.00 0.00

Conglomerates

3.72 0.00 0.00

Manufacturing

2.75 0.00 0.00
Asset Allocation (%) (Mar 31, 18)
Class
%

Equity

94.28

Others / Unlisted

0.13

Debt

0.00

Mutual Funds

N.A

Money Market

6.15

Cash / Call

-0.56

Net Receivable / Payable

N.A
Concentration
Holdings
%

Top 5

39.62

Top 10

62.74
Sectors
%

Top 3

91.53
Sections
Follow us on
Available On